Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.37 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.36 |
| ▸ | CDC25A | P30304 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CCKBR | P32239 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3373741 | 0.75 | CA12 (0.53) | CA12CA9MEN1KMT2ACDC25A | |
| SCHEMBL29548009 | 0.75 | ADRA2A (0.32) | MEN1KMT2ASMN1; SMN2KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL28765836 | 0.74 | SLC6A2 (0.31) | MEN1KMT2AKDM4EALDH1A1 | |
| Perchlorate SCHEMBL30296132 | 0.71 | HDAC4 (0.38) | MEN1KMT2ASMN1; SMN2L3MBTL1TSHR | |
| Perchlorate SCHEMBL31322477 | 0.71 | — | — | |
| SCHEMBL9618341 | 0.71 | CA12 (0.65) | CA12CA9MEN1KMT2AKDM4E | |
| SCHEMBL10826562 | 0.71 | CA12 (0.45) | CA12CA9MEN1KMT2ACDC25A | |
| SCHEMBL28383957 | 0.71 | CHEK1 (0.36) | MEN1KMT2ASMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL28450185 | 0.70 | — | — | |
| SCHEMBL19673997 | 0.68 | CA12 (0.49) | CA12CA9MEN1KMT2ACDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100184818-A1 | PHOTOSENSITIZERS FOR TARGETED PHOTODYNAMIC THERAPY | THE GENERAL HOSPITAL CORPORATION (US) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184818-A1 | PHOTOSENSITIZERS FOR TARGETED PHOTODYNAMIC THERAPY | PPOX, PPIF, HCCS | CA12 328/4885CA9 618/4885CRHBP 3759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.